vTely321 transcriptome confirms its transgenic origin
We previously showed that manual and chemogenetic ablations of vTely321 neurons disrupts zebrafish social orienting behavior (Stednitz et al., 2018), prompting us to further understand this cell population. vTely321 neurons are genetically defined by the enhancer trap insertion Et(rex2-scp1:gal4ff)y321: UAS;GFP) (Fig. 1a) and lie within the Ventral ventral (Vv) and Ventral dorsal (Vd) nuclei of the zebrafish telencephalon. To learn the molecular identity of this population of neurons, we randomly selected and dissected and dissociated heads of 7-day post-fertilization (dpf) larvae (n = 80) to isolate as much of the forebrain as possible (Fig. 1A). After dissociation, we used fluorescence-activated cell sorting (FACS) to sort, pool, and sequence at least 100,000 sorted GFP positive and negative cells from each sample (Fig. 1A’). 80–90% of dissociated cells were alive (Fig. 1A’’) and 3.69% of these cells were GFP positive (Fig. 1A’’’). We expected the proportion of GFP positive cells to be small because the vTely321 nucleus is a relatively limited portion of the forebrain, totaling several hundred neurons at this stage (Bruckner et al., 2020). We used Ensembl to select protein-encoding genes and compiled lists of genes, ordered by adjusted P values, that are differentially expressed (DE) between GFP positive and GFP negative cells. Principal component analysis revealed that one sample from the GFP negative fraction was an outlier (Fig. 1B). This sample was dropped leaving us with 3 GFP positive samples and 2 GFP negative samples. Sorting for genes with an adjusted P value ≤ 0.05 generated a list of 2,096 DE genes expressed in GFP positive cells compared to GFP negative cells out of a total of ~ 23,000 genes (9%).
To refine our characterization of vTely321 neurons, we focused on genes documented to be expressed in the forebrain by the Zebrafish Information Network (ZFIN; zfin.org), compiling a list of 454 genes (21.6% of the 2,096 DE genes). When we reviewed the top 20 differentially expressed genes from the entire dataset and the top 20 forebrain genes (Fig. 1D-E), we discovered that the LIM transcription factor (LIMTF) encoding gene lhx8a (Fig. 1C) was highly enriched in the GFP positive population of neurons. We had expected to observe significant enrichment of lhx8a in GFP positive neurons since the enhancer trap Ety321 is located within the lhx8a gene locus (Zebrafish Brain Browser, zbbrowser.org) (Additional Table 1). Taken together with the high enrichment of EGFP transcripts in the GFP positive population (Fig. 1D), we conclude that the dataset successfully represents an enriched population of mRNAs from the FACS sorted cells.
Table 1
Neurotransmitter-associated genes expressed in vTely321 neurons
Symbol | Gene name | p-adjusted | Log2Fold change | Neurotransmitter |
slc17a6b | vglut2 | 0.13842785 | -0.563783931 | Glutamate |
slc17a6a | vglut2.2 | 0.97372783 | 0.094682805 |
slc1a2b | EAAT2 Glutamate transporter | 5.99E-12 | 1.280660763 |
slc1a2a | EAAT2b | 0.07570601 | 1.645158684 |
slc18a3b | vachtb | 0.52629943 | -1.883485129 | Acetylcholine |
slc6a7 | Choline transporter | 0.00040338 | -8.21997693495 |
slc18a3a | vachta | 0.99634064 | -0.015324035 |
Chata | chata | 0.19918698 | -0.893354429 |
slc18a2 | vmat2 | 0.8983514 | 0.533626413 | Dopamine |
slc6a3 | DAT | 0.10773861 | -0.850246803 |
slc6a2 | NE transporter | 0.68157586 | 0.533626413 | Norepinephrine |
slc32a1 | vgat | 0.00039023 | -1.01476333 | GABA |
slc6a1b | gat | 0.00043843 | -0.593364614 |
gad1b | gad67b/gad1b | 0.11640804 | 0.413463156 |
gad2 | gad65/gad2 | 6.19E-06 | -1.01827851 |
Gcat | glycine C-acetyltransferase | 0.58087894 | -0.660647133 | Glycine |
slc6a5 | glycine transporter 2(glyt2) | 0.01674848 | -2.009676284 |
Highlighted genes are significantly DE with enhanced expression in vTely321 neurons denoted by an adjusted p-value (p < 0.05) and negative Log2Fold change. The letters slc denote genes belonging to the solute carrier superfamily of genes. |
vTely321 neurons express two classical NTs
The rodent lhx8a homolog, Lhx8, is required for development of cholinergic neurons in the rat forebrain (Zhao, 2003), and we previously showed that vTely321 neurons are cholinergic (Stednitz et al., 2018). Consistent with our previous observations, ISH confirmed detection of transcripts for cholinergic markers such as the vesicular acetylcholine transporter (vachtb, n = 4) (Fig. 2A and 2A’) and choline acetyltransferase (chatb, n = 4) in vTely321 neurons (Additional Fig. 1). In addition, we also found significant differential expression of slc5a7, encoding the choline transporter, further validating the cholinergic identity of these neurons. We compiled a list of NT markers that were expressed, and established which ones were significantly DE (Table 1). We were surprised that, in addition to cholinergic transcripts, vTely321 neurons also express several GABAergic specific transcripts including slc32a1 (the vesicular GABA transporter, vgat) and glutamate decarboxylase genes gad2 and gad1b (Table 1), suggesting that vTely321 neurons are both GABAergic and cholinergic.
To determine if individual vTely321 neurons are cholinergic-GABAergic neurons (CGNs), we combined GABA immunolabeling and ISH for vachtb or chatb. We found that vTely321 neurons are both cholinergic and GABAergic (Fig. 2B) based on expression of both vachtb (Fig. 2A) and chatb (Additional Fig. 1) overlapping with GABA staining. Approximately 92% (1,183/1,287) of GFP positive cells were GABAergic and 85% (1,093/1,287) were cholinergic. At selected anatomical positions (Fig. 2B and Methods) we found that approximately 91 ± 4.9% (670/733) of vTely321 neurons in the rostral telencephalon (RT) are CGNs, expressing both cholinergic and GABAergic properties (Fig. 2C). At the mid-telencephalon position, 84.5 ± 9.31% (181/215) neurons were CGNs. The average proportion of vTely321 neurons that are CGNs in the caudal telencephalon (CT) was 74.15 ± 22.9% (284/383) (Fig. 2C). In the RT and MT, vTely321 neurons are largely located in the Vv and Vd though some are scattered in the dorsal pallium. We conclude that although the proportion of vTely321 neurons that are CGNs is consistently large across the telencephalon, this proportion decreases in the rostral to caudal direction.
The CGN phenotype is constant throughout development
Previous studies suggest that NT fate acquisition could be sequential, in which neurons first develop as single NT neurons and later express an additional NT (Spitzer, 2012, 2017, Li et al., 2020). To learn whether vTely321 neurons develop their cholinergic and GABAergic fates in a particular order, or whether that order differed along the telencephalic axis of these neurons, we examined when they attained their multi-NT phenotype, and whether it occurred sequentially. If the CGN phenotype was attained in a sequential manner, we would expect to see varying proportions of vTely321 neurons that were CGNs. To determine if this was the case, we in-crossed Ety321 [Et(rex2-scp1:gal4ff)y321] fish, raised the resultant F1 embryos to 7 dpf, and performed IHC labeling for cholinergic and GABAergic markers at multiple stages of development. These experiments enabled us to determine that the y321 transgene begins driving GFP expression in vTely321 neurons at 24 hpf. This was also the earliest timepoint we could detect GABAergic and cholinergic markers (Fig. 3A-A”), and the labeling was consistent across development (Fig. 3A-A”,B-B”,C-C”). These results suggest that CGNs attain their multi-NT identity very early in development and maintain it throughout life.
To learn whether the number of CGN vTely321 varies from rostral to caudal during early development, we quantified the proportion of CGN vTely321 neurons at 2 and 4 dpf at rostral, medial, and caudal forebrain positions. At least 80% of vTely321 neurons we quantified are CGNs at 2 (81.86±10.08%, n = 4) and 4 dpf (85.99±7.15%, n = 4) (Fig. 3D). Though the general trend between 2 and 4 dpf is an increase in the percentage of CGN vTely321 neurons, the increase is not statistically significant (T(19.8) = -0.59, p = 0.55, n = 8). In addition, there is also a general decrease in the percentage of vTely321 neurons that are CGN multi-transmitter neurons in the rostral to caudal direction. At 2 dpf, 93±3.21% of vTely321 neurons quantified at the RT position are CGNs and the figure declines to 85.45±2.93% at MT and 73.12 ± 9.23% at CT. At 4 dpf, 92 ± 4.73% of vTely321 neurons at the RT position are CGNs, and 87.05 ± 1% at MT are CGNs and 82.31 ± 9.23% at the CT position are CGNs. Overall, the trend we observed in the proportion of vTely321 neurons that are CGNs in adults is replicated at 2 and 4 dpf.
LIMTF genes are expressed in vTely321 neurons throughout development
Two LIMTF genes, lhx6 and lhx8a, are highly expressed in vTely321 neurons (Fig. 1C and Fig. 1E). These genes show the highest DE between GFP positive and GFP negative neurons. ISH with anti-sense ribo-probes for these genes showed that they are both expressed in adult vTely321 neurons (Fig. 4A-A”,B-B”). To determine when these transcription factors were first expressed, we in-crossed Ety321 [Et(rex2-scp1:gal4ff)y321] fish and performed ISH and IHC on their offspring to detect forebrain expression of LIMTF genes. The earliest time point at which we detected LIMTFs was approximately 20 hpf (n = 12) (Fig. 4D, E); at this stage, lhx6 and lhx8a forebrain expression is restricted to four principal clusters. These clusters have previously been described for lhx8a as telencephalic and diencephalic clusters (Thisse et al., 2001). It is likely that these clusters give rise to the population of neurons later marked by expression of the transgene vTely321.
There is evidence that during development, another LIMTF gene, isl1, is expressed in the ventral floor plate region of the telencephalon (Wullimann, 2019). Our bulk sequencing data confirmed that isl1 is highly differentially expressed in vTely321 neurons (Additional Table 1). In addition, since isl1 expression is typically used as a marker for cholinergic neurons (Cho et al., 2014) and we know that vTely321 neurons are cholinergic, we asked whether isl1 expression is detectable in vTely321 neurons, and if so, when. isl1 expression was detected at 20 hpf in the embryonic forebrain in similar clusters (Fig. 4D-F) as lhx6 and lhx8a. We also established that this expression is constant throughout development and can be detected in vTely321 neurons in adult forebrain (Fig. 4C-C”). Additionally, labeling at 24 hpf, once GFP expression from the y321 Et driver is visible, confirms that all 3 LIMTF genes are expressed within vTely321 neurons (Fig. 4G-G”, H-H”,I-I”). Together these observations indicate that the 3 LIMTF genes are reliable in identifying vTely321 neurons and that they are expressed throughout the life of those neurons, beginning by the end of the first day of development.
The vTely321 “transcriptomic fingerprint” is evolutionarily conserved
Multi-NT neurons are a common feature across vertebrates. However, a major challenge is locating homologous neurons in different vertebrate species. Locating homologous neurons across the vertebrate phyla will enable us to better understand the phylogeny of specific behaviors regulated by multi-transmitter neurons. We were thus interested in examining whether vTely321 neurons are conserved in other vertebrates. To do this, we examined expression of the LIMTF genes, lhx8a, lhx6, and isl1, and the NT pathway genes gad1 and chat, in existing cell sequencing databases. First, we compared our bulk RNAseq-data with single cell RNA-sequencing data from 1, 3 and 7 dpf zebrafish, which was compiled into the Atlas of Zebrafish Development (Farnsworth et al., 2020). Based on expression of the transcriptomic fingerprint from our bulk RNAseq experiments described above, vTely321 neurons map to Cluster 25 of the scRNA-seq Atlas (Fig. 5A). Our dataset of enhanced and statistically significant DE genes was shared with 654 genes from Cluster 25, and therefore served as additional validation of our FACS-based transcriptomic analysis. 212 of the 654 shared genes were classified as forebrain specific using the ZFIN classification.
We turned our attention to the key genes in our proposed transcriptomic fingerprint, such as the LIMTF genes, and found that all 3 of these genes are significantly expressed in Cluster 25 (Fig. 5B). Interestingly, the ohnolog for lhx8a, lhx8b was also highly expressed in the shared cluster. The data also reveal high expression of GABAergic NT markers such as the glutamate decarboxylase genes (gad1b, gad2) and other GABAergic markers such as vesicular GABA transporter (vgat), and the GABA Transporter 1 (gat1). There was low expression of chata across Cluster 25, however, we previously detected its ohnolog chatb in vTely321 neurons using ISH. Unfortunately, chatb is not annotated in the Atlas gene list due to inconsistencies in genome alignment, so we were therefore unable to assess its expression via transcriptome analysis. Nevertheless, we felt confident utilizing chata in our analysis because there were also other cholinergic markers that we obtained through bulk RNA-sequencing.
Next, utilizing the three murine LIMTF genes (Lhx6, Lhx8, Isl1) and murine NT marker genes (Gad1 and Chat), we searched for a homologous population of neurons in mice using the Linnarsson Lab scRNA-seq brain atlas (http://mousebrain.org/genesearch.html) .The mouse brain atlas consists of 265 clusters segregated based on expression of tissue specific transcripts. Using the online atlas, we located two similar clusters of neurons in the telencephalon and diencephalon (Fig. 5C) denoted TECHO and DECHO1. These clusters correlate well with our data in which the LIMTF genes are expressed in two clusters, telencephalic and diencephalic (Fig. 4D-F). To test whether our transcriptomic fingerprint was unique to telencephalic and diencephalic clusters, we searched through the mouse brain atlas for other cholinergic clusters and asked whether they bore the same signature. There were six other clusters that were classified as cholinergic neurons, four of these are in the hindbrain (HBCHO1-4), one located in the midbrain (MBCHO4), and one located in the diencephalon (DECHO2) (Fig. 5C). None of these clusters expressed all the genes in our transcriptomic fingerprint, suggesting that the fingerprint is highly specific for CGN vTely321 neurons.